Ads
related to: Astellas PharmaConnect with a representative for support with public interest pricing and ordering today. Explore clinical pharmacology data, indication, and important safety information.
- Contact Us
Learn more about OPVEE®.
See availability in your area.
- How to Use OPVEE®
Place, Press, Pause.
Quick start guide.
- What is OPVEE®?
See how OPVEE® is different.
Explore indication.
- A Public Health Crisis
Latest facts and statistics.
Track evolving conditions.
- Additional Resources
Quick start guide.
Educational materials.
- How to Get OPVEE®?
Pricing and availability.
Help with ordering.
- Contact Us
Astellas Oncology is reimagining the patient experience through our patient commitment. Our team incorporates real-world perspectives of patients into our process.
Clinical-grade Active Pharmaceutical Ingredient apo for clinical research. Clinical-grade Active Pharmaceutical Ingredient API for clinical research.
Search results
May 28, 2024 · Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.
- Partnering
Why Partner with Astellas We apply a long-term, strategic...
- Careers
Developing innovative therapies is one of the most...
- Suppliers
Here our current and prospective suppliers can find...
- Contact Us
Contact Astellas Pharma Inc. Location: 2-5-1,...
- WORLDWIDE
Poland - Astellas Pharma Sp.zo.o. Portugal - Astellas Farma...
- Innovation
Astellas believes that application of cutting-edge science &...
- Sustainability
Improving sustainability requires effort, and Astellas...
- About
Thank you for visiting the Astellas Pharma Inc. Website. ......
- Investor Relations
Astellas Pharma Inc. Astellas' IR news. Financial Results,...
- News
TOKYO, May 30, 2024 – Astellas Pharma Inc. (TSE: 4503,...
- Partnering
May 20, 2024 · Access financial information, investor relations library, analyst coverage and more. Astellas Pharma brings brighter futures to patients, physicians, communities and employees as a new kind of pharmaceutical company.
Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. (山之内製薬株式会社, Yamanouchi Seiyaku Kabushiki-gaisha) and Fujisawa Pharmaceutical Co., Ltd ...
Astellas Pharma U.S., Inc. is committed to providing patients, customers, communities and employees with a bright future... U.S. Leadership. Learn more about Astellas leaders. Vision & Strategy. On the forefront of healthcare change to turn innovative science into value for patients. Philosophy.
Of the many R&D programs Astellas has underway, 22 are related to our Rx (prescription drug) business. We also advance Rx+ ® business, which aims to contribute to patients across the whole patient journey (overall medical care, including diagnostic, preventive, therapeutic and prognostic care).
- 103,001 million yen (March 2023)
- 1923
- Astellas Pharma Inc.
May 12, 2023 · Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause. VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause. TOKYO, May 12, 2023 / PRNewswire / -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura ...
People also ask
Who is Astellas Pharma?
What does Astellas do?
Is Astellas a Japanese company?
Does Astellas provide medical advice?
Astellas is committed to creating innovative drugs with cutting-edge science that can address areas of high unmet medical needs. We aim to help patients who have no treatment options, or do not respond adequately to existing treatments.
Ads
related to: Astellas PharmaConnect with a representative for support with public interest pricing and ordering today. Explore clinical pharmacology data, indication, and important safety information.
Astellas Oncology is reimagining the patient experience through our patient commitment. Our team incorporates real-world perspectives of patients into our process.
